NCT06624644 2026-04-22
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Linnaeus Therapeutics, Inc.
Phase 2/3 Recruiting
Clinical Trials
6 trialsNCT04594187 2026-02-17
MelPORT
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT07407166 2026-02-17
Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers
Institute of Oncology Ljubljana
Phase NA Recruiting
NCT06627595 2024-11-15
APiTOXMM
University Hospital, Montpellier
Recruiting
NCT05229614 2024-08-21
ICONIC
CNAO National Center of Oncological Hadrontherapy
Phase 2 Recruiting
NCT05478876 2024-08-21
CYCLE
CNAO National Center of Oncological Hadrontherapy
Phase NA Recruiting